HTA and pricing update: Recent moves on drug cost-control by European payers

By Chloe Sheppard, Analyst Email: csheppard@partners4access.com The issue of affordability and access to medicines has been brought to the forefront of policymakers’ and payers’ attention in Europe thanks to the COVID-19 pandemic. Summarised below are some recent changes to HTA and pricing processes and discussions from payers across Italy, Germany and Spain, which highlight how…